BlackRock Institutional Trust’s Biolase, Inc. BIOL Stock Holding History

BlackRock Institutional Trust’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.92M	Hold	110	–	–	﹤0.01%	3060
2016 Q3	$2.4M	Hold	110	–	–	﹤0.01%	2978
2016 Q2	$1.61M	Hold	110	–	–	﹤0.01%	3123
2016 Q1	$1.8M	Hold	110	–	–	﹤0.01%	3079
2015 Q4	$1.16M	Hold	110	–	–	﹤0.01%	3291
2015 Q3	$1.24M	Hold	110	–	–	﹤0.01%	3274
2015 Q2	$2.38M	Buy	110 +4	+4%	+$97.5K	﹤0.01%	3047
2015 Q1	$2.67M	Buy	106 +5	+5%	+$142K	﹤0.01%	2982
2014 Q4	$3.32M	Buy	101 +1	+1%	+$31.3K	﹤0.01%	2898
2014 Q3	$3.13M	Buy	100 +5	+5%	+$141K	﹤0.01%	2879
2014 Q2	$2.61M	Sell	95 -23	-19%	-$587K	﹤0.01%	3075
2014 Q1	$3.54M	Sell	118 -1	-0.8%	-$34.9K	﹤0.01%	2918
2013 Q4	$4.19M	Buy	119 +15	+14%	+$356K	﹤0.01%	2864
2013 Q3	$2.46M	Buy	104 +17	+20%	+$548K	﹤0.01%	3027
2013 Q2	$3.8M	Buy	+87	New	+$4.86M	﹤0.01%	2819

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock Institutional Trust's BIOL Position: Q4 2016 in Review

BlackRock Institutional Trust held its Biolase, Inc. (BIOL) position steady in Q4 2016 at 110 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #3060.

BlackRock Institutional Trust first reported a position in BIOL in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.19M in Q4 2013. 34 funds tracked by Wall St. Rank hold BIOL as of Q4 2016.

BlackRock Institutional Trust held 110 shares of Biolase, Inc. worth $1.92M as of Q4 2016.
BlackRock Institutional Trust left its Biolase, Inc. share count unchanged in Q4 2016.
Biolase, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3060 holding.
BlackRock Institutional Trust first reported a position in Biolase, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Biolase, Inc. position peaked at $4.19M in Q4 2013.
34 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.